Dr. Wahl is a physician scientist and a tenured Associate Professor of Radiation Oncology and Neurosurgery at the University of Michigan. He obtained his MD and PhD degrees in 2012 from the University of Michigan where he studied Chemical Biology and immunometabolism under the mentorship of Drs. Gary Glick and Jamie Ferrara.  He then underwent clinical training in radiation oncology at the University of Michigan and a postdoctoral fellowship studying brain tumor biology, metabolism and the DNA damage response under the mentorship of Dr. Theodore Lawrence. During his training he published important works on metabolic rewiring in immune diseases and new approaches to irradiate glioblastoma and hepatocellular carcinoma. In 2017, he joined the faculty of the University of Michigan as a physician scientist whose clinical practice and research program focus on improving outcomes for patients with aggressive brain tumors. In the laboratory, Dr. Wahl and his team have discovered numerous mechanistic links between altered metabolism, DNA repair and treatment resistance in brain cancers such as glioblastoma and diffuse intrinsic pontine glioma. His research team has translated this laboratory work into clinical studies that measure metabolism in brain tumor patients using stable isotope tracing and inhibit it through therapeutic clinical trials. His work has been published in leading journals including the Journal of Clinical Oncology, Cancer Discovery, Nature Communications, Science Translational Medicine and others. His work has been funded by numerous sources including K08, R37 and SPORE awards from the NCI and an R01 from the NINDS. Dr. Wahl has been recognized for his work by receiving numerous awards including a Clinical Investigator Award from the Damon Runyon Cancer Foundation, a Distinguished Scientist Award from the Sontag Foundation, and an Emerging Leader Award from the Ben and Cathy Ivy Glioblastoma Foundation.